ANI Pharmaceuticals, Inc. (ANIP)
72.83
-0.68
(-0.92%)
USD |
NASDAQ |
Aug 28, 16:00
72.83
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Free Cash Flow : 167.52M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 167.52M |
| March 31, 2026 | 182.81M |
| December 31, 2025 | 150.90M |
| September 30, 2025 | 136.04M |
| June 30, 2025 | 105.18M |
| March 31, 2025 | 49.24M |
| December 31, 2024 | 47.78M |
| September 30, 2024 | 73.64M |
| June 30, 2024 | 94.23M |
| March 31, 2024 | 95.06M |
| December 31, 2023 | 100.45M |
| September 30, 2023 | 52.94M |
| June 30, 2023 | 19.14M |
| March 31, 2023 | -7.467M |
| December 31, 2022 | -47.66M |
| September 30, 2022 | -52.67M |
| June 30, 2022 | -52.46M |
| March 31, 2022 | -61.37M |
| December 31, 2021 | -20.32M |
| September 30, 2021 | -15.59M |
| June 30, 2021 | -17.03M |
| March 31, 2021 | 22.71M |
| December 31, 2020 | -53.06M |
| September 30, 2020 | -41.80M |
| June 30, 2020 | -14.51M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.76M |
| December 31, 2019 | 18.08M |
| September 30, 2019 | 39.46M |
| June 30, 2019 | 26.39M |
| March 31, 2019 | 27.94M |
| December 31, 2018 | 54.59M |
| September 30, 2018 | -4.526M |
| June 30, 2018 | 3.284M |
| March 31, 2018 | -1.357M |
| December 31, 2017 | -68.57M |
| September 30, 2017 | -23.28M |
| June 30, 2017 | -37.89M |
| March 31, 2017 | -93.57M |
| December 31, 2016 | -121.59M |
| September 30, 2016 | -128.98M |
| June 30, 2016 | -145.50M |
| March 31, 2016 | -86.51M |
| December 31, 2015 | -15.42M |
| September 30, 2015 | -8.613M |
| June 30, 2015 | -10.45M |
| March 31, 2015 | -9.757M |
| December 31, 2014 | -13.72M |
| September 30, 2014 | -27.02M |
| June 30, 2014 | -10.31M |
| March 31, 2014 | -8.986M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viatris, Inc. | 1.806B |
| Liquidia Corp. | 150.69M |
| Elanco Animal Health, Inc. | 379.00M |
| Harmony Biosciences Holdings, Inc. | 335.65M |
| Corcept Therapeutics, Inc. | 106.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 56.67M |
| Cash from Investing (Quarterly) | -3.054M |
| Cash from Financing (Quarterly) | -4.647M |
| Free Cash Flow Per Share (Quarterly) | 2.446 |
| Free Cash Flow to Equity (Quarterly) | 56.88M |
| Free Cash Flow to Firm (Quarterly) | 58.61M |
| Free Cash Flow Yield | 10.66% |